Cover Image
市場調查報告書

非口服營養的全球市場:營養物的各類型 (碳水化合物、非口服脂肪乳劑、單劑量氨基酸溶液、微量礦物質、維生素和礦物質)、各地區的未來預測

Parenteral Nutrition Market Analysis, By Nutrition Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals) And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 361259
出版日期 內容資訊 英文 91 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
非口服營養的全球市場:營養物的各類型 (碳水化合物、非口服脂肪乳劑、單劑量氨基酸溶液、微量礦物質、維生素和礦物質)、各地區的未來預測 Parenteral Nutrition Market Analysis, By Nutrition Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals) And Segment Forecasts To 2024
出版日期: 2016年05月29日 內容資訊: 英文 91 Pages
簡介

全球非口服營養的市場規模,2024年預計達到73億美元。在各地區中美國為最大的市場,尤其是由於非口服營養在居家醫療也能使用,以心臟病患者為中心需求擴大。還有中國、印度等開發中國家市場也急速擴大。

本報告提供全球非口服營養市場相關分析,整體市場規模的變化、預測 (過去3年、今後9年份) ,及主要推動及阻礙市場要素,各營養素、各地區的詳細趨勢,主要企業簡介、市場佔有率等調查評估。

第1章 分析方法、範圍

第2章 摘要整理

  • 非口服營養市場:產業的最新趨勢主要購買標準

第3章 非口服營養產業的未來展望

  • 市場明細
  • 市場規模、成長率預測
  • 非口服營養市場動態
    • 推動市場要素分析
      • 老年人口的增加
      • 慢性疾病的盛行率的上升 (癌症、AIDS、腸胃疾病)
    • 阻礙市場要素分析
      • 輸液注射中的感染風險高
      • 選擇經腸營養的趨勢擴大
  • 重要度高的市場機會
  • 波特的五力分析
  • 主要企業的市場佔有率/競爭情形
  • 非口服營養市場的PESTEL分析

第4章 非口服營養市場的未來展望:營養物的各類型

  • 營養物的各種類的市場佔有率 (最新值、預測值)
  • 碳水化合物
    • 市場規模的估計值、預測值 (以金額為準,總計12年份)
  • 非口服脂肪乳劑
  • 單劑量氨基酸溶液
  • 微量礦物質
  • 維生素和礦物質

第5章 非口服營養市場的未來展望:各地區

  • 各地區的市場佔有率 (最新值、預測值)
  • 北美
    • 市場規模的估計值、預測值:營養物的各類型 (以金額為準,總計12年份)
      • 美國市場
      • 加拿大市場
  • 歐洲
    • 市場規模的估計值、預測值:營養物的各類型 (以金額為準,總計12年份)
      • 德國市場
      • 英國市場
  • 亞太地區
    • 市場規模的估計值、預測值:營養物的各類型 (以金額為準,總計12年份)
      • 日本市場
      • 中國市場
  • 南美
    • 市場規模的估計值、預測值:營養物的各類型 (以金額為準,總計12年份)
      • 阿根廷市場
      • 巴西市場
  • 中東、非洲
    • 市場規模的估計值、預測值:營養物的各類型 (以金額為準,總計12年份)
      • 南非
      • 沙烏地阿拉伯

第6章 競爭環境

  • B. Braun Melsungen AG
    • 企業概要
    • 財務成果
    • 產品比較分析
    • 策略性配合措施
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Actavis, Inc.
  • Grifols International S.A.
  • 大塚製藥工廠
  • Sichuan Kelun Pharmaceutical Co. Ltd.

圖表一覽

目錄
Product Code: 978-1-68038-867-1

The global parenteral nutrition market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing natality rate, the growing malnutrition coupled with the prevalence of chronic conditions such as cancer and gastro-intestinal tract diseases are expected to boost the market over the forecast period.

The presence of malnourished children in the developing countries leading to the rise in the natality rate and the rising geriatric population suffering from a deficiency of essential nutrients are some of the major factors that are expected to fuel the global parenteral nutrition market.

According to the WHO around 40.0% patients across the world were malnourished in 2010. The study also indicated that about one-third of the patients in Europe were malnourished in 2012, thereby fueling industry growth.

According to the statistics provided by the World Bank Group, India had the highest natality rate followed by China in 2012. Moreover, a consistent increase in the rate of natality was observed in the European countries such as the U.K. and France. Therefore, Asia Pacific and Europe are expected to witness the fastest growth over the forecast.

North America is expected to witness lucrative growth due to the increase in consumer awareness paired with the increasing healthcare costs. As parenteral nutrition products are available in the home health care sector, it further facilitates the market growth due to the increasing trend in home health care. The increasing incidence of heart diseases is another vital driver. According to the WHO around 49.0% of the American population is endangered with the risk of cardiac arrest.

Further key findings from the study suggest:

  • North America is expected to dominate the overall market with a revenue share of about40.0% in 2024, owing to the increasing incidences of heart diseases coupled with the rise in home health care.
  • Asia Pacific and Europe are anticipated to be the fastest growing region with a CAGR of over5.5% over the forecast period. The rise in the natality rate, rising geriatric population and the growing awareness regarding the importance of nutritional value and its impact on health are the vital impact rendering drivers for the region.
  • Key players of the industry include Baxter International, Inc., Hospira, Inc., B. Braun Melsungen AG, Grifols International S.A., Fresenius Kabi AG, Otsuka Pharmaceutical Factory, Inc., Actavis, Inc., Sichuan Kelun Pharmaceutical Co., Ltd. Most of these companies have been in the business for over a decade and are bringing in expertise and technological advancements that are expected to help them sustain over the forecast period.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Parenteral Nutrition Market- Industry Snapshot and Key Buying Criteria, 2015

Chapter 3. Parenteral Nutrition Industry Outlook

  • 3.1. Parenteral Nutrition Market Segmentation
  • 3.2. Parenteral Nutrition Market Size and Growth Prospects
  • 3.3. Parenteral Nutrition Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Growing base of geriatric population
      • 3.3.1.2. Growing prevalence of chronic diseases
        • 3.3.1.2.1. Cancer
        • 3.3.1.2.2. AIDS
        • 3.3.1.2.3. Gastrointestinal Disorders
      • 3.3.1.3. Increasing incidences of malnutrition
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High risk of infection during administration of fluids
      • 3.3.2.2. Increasing preference for enteral nutrition
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry Analysis - Porter's
  • 3.6. Parenteral Nutrition Company Market Share/Competitive Landscape, 2015
  • 3.7. Parenteral Nutrition Market PESTEL Analysis, 2015

Chapter 4. Parenteral nutrition Type Of Nutrition Outlook

  • 4.1. Market Share, By Type of Nutrition, 2015 & 2024
  • 4.2. Carbohydrates
    • 4.2.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
  • 4.3. Parenteral Lipid Emulsion
    • 4.3.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
  • 4.4. Single Dose Amino Acid Solution
    • 4.4.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
  • 4.5. Trace Elements
    • 4.5.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
  • 4.6. Vitamins and Minerals
    • 4.6.1. Market Estimates and Forecasts, 2013 - 2024

Chapter 5. Parenteral Nutrition Regional Outlook

  • 5.1. Market Share By Region, 2015 & 2024
  • 5.2. North America
    • 5.2.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
      • 5.2.1.1. U.S. Market Estimates and Forecasts
      • 5.2.1.2. Canada Market Estimates and Forecasts
  • 5.3. Europe
    • 5.3.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
      • 5.3.1.1. Germany Market Estimates and Forecasts
      • 5.3.1.2. UK Market Estimates and Forecasts
  • 5.4. Asia Pacific
    • 5.4.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
      • 5.4.1.1. Japan Market Estimates and Forecasts
      • 5.4.1.2. China Market Estimates and Forecasts
  • 5.5. Latin America
    • 5.5.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
      • 5.5.1.1. Argentina Estimates and Forecasts
      • 5.5.1.2. Brazil Estimates and Forecasts
  • 5.6. MEA
    • 5.6.1. MEA Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
      • 5.6.1.1. South Africa Estimates and Forecasts
      • 5.6.1.2. Saudi Arabia Estimates and Forecasts

Chapter 6. Competitive Landscape

  • 6.1. B. Braun Melsungen AG
    • 6.1.1. Company Overview
    • 6.1.2. Financial Performance
    • 6.1.3. Product Benchmarking
    • 6.1.4. Strategic Initiatives
  • 6.2. Baxter International, Inc.
    • 6.2.1. Company Overview
    • 6.2.2. Financial Performance
    • 6.2.3. Product Benchmarking
    • 6.2.4. Strategic Initiatives
  • 6.3. Fresenius Kabi AG
    • 6.3.1. Company Overview
    • 6.3.2. Financial Performance
    • 6.3.3. Product Benchmarking
    • 6.3.4. Strategic Initiatives
  • 6.4. Hospira, Inc.
    • 6.4.1. Company Overview
    • 6.4.2. Financial Performance
    • 6.4.3. Product Benchmarking
    • 6.4.4. Strategic Initiatives
  • 6.5. Actavis, Inc.
    • 6.5.1. Company Overview
    • 6.5.2. Financial Performance
    • 6.5.3. Product Benchmarking
    • 6.5.4. Strategic Initiatives
  • 6.6. Grifols International S.A.
    • 6.6.1. Company Overview
    • 6.6.2. Financial Performance
    • 6.6.3. Product Benchmarking
    • 6.6.4. Strategic Initiatives
  • 6.7. Otsuka Pharmaceutical Factory, Inc.
    • 6.7.1. Company Overview
    • 6.7.2. Financial Performance
    • 6.7.3. Product Benchmarking
    • 6.7.4. Strategic Initiatives
  • 6.8. Sichuan Kelun Pharmaceutical Co. Ltd.
    • 6.8.1. Company Overview
    • 6.8.2. Financial Performance
    • 6.8.3. Product Benchmarking
    • 6.8.4. Strategic Initiatives

List of Tables

  • 1. Parenteral nutrition - Industry Snapshot
  • 2. Parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 3. Parenteral nutrition market, by region, 2013 - 2024 (USD billion)
  • 4. Parenteral nutrition market - Key market drivers analysis
  • 5. Parenteral nutrition market - Key market restraints analysis
  • 6. North America parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 7. U.S. parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 8. Canada parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 9. Europe parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 10. UK parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 11. Germany parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 12. Asia Pacific parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 13. Japan parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 14. China parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 15. Latin America parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 16. Brazil parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 17. Mexico parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 18. MEA parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 19. South Africa parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
  • 20. Saudi Arabia parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)

List of Figures

  • 1. Parenteral nutrition market segmentation
  • 2. Global parenteral nutrition market revenue, 2013 - 2024
  • 3. Parenteral nutrition market dynamics
  • 4. Key opportunities prioritized
  • 5. Parenteral nutrition market Analysis - Porter's
  • 6. Parenteral nutrition market Analysis - PESTEL Analysis
  • 7. Global parenteral nutrition market , by type of nutrition, 2013 - 2024 (USD billion)
  • 8. Carbohydrate market, 2013 - 2024 (USD billion)
  • 9. Parenteral lipid emulsion market, 2013 - 2024 (USD billion)
  • 10. Single dose amino acid solution market, 2013 - 2024 (USD billion)
  • 11. Trace elements market, 2013 - 2024 (USD billion)
  • 12. Vitamins and minerals market, 2013 - 2024 (USD billion)
  • 13. Global parenteral nutrition market , by region 2013 to 2024 (USD billion)
  • 14. North America parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 15. U.S. parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 16. Canada parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 17. Europe parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 18. UK parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 19. Germany parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 20. Asia Pacific parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 21. Japan parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 22. China parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 23. Latin America parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 24. Brazil parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 25. Mexico parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 26. MEA parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 27. South Africa parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
  • 28. Saudi Arabia parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
Back to Top